The Effect of Immunoproteasome Inhibition on T Helper Cells in Acute Inflammation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Konstanz, Universität Konstanz, Dissertation, 2022
- Keyword
-
Proteasom
Immunreaktion
- Event
-
Veröffentlichung
- (where)
-
Konstanz
- (who)
-
KOPS Universität Konstanz
- (when)
-
2022
- Creator
-
Oliveri, Franziska
- URN
-
urn:nbn:de:bsz:352-2-rvt0h1h7c5925
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Oliveri, Franziska
- KOPS Universität Konstanz
Time of origin
- 2022
Other Objects (12)
Immunoproteasome inhibition reduces the T helper 2 response in mouse models of allergic airway inflammation
Immunoproteasome Inhibition Reduces the T Helper 2 Response in Mouse Models of Allergic Airway Inflammation
Immunoproteasome inhibition attenuates experimental psoriasis
Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation
No prolongation of skin allograft survival by immunoproteasome inhibition in mice
The role of immunoproteasome subunit LMP7 in modulating T-helper cell differentiation and progression of autoimmune diseases
Recent insights how combined inhibition of immuno/proteasome subunits enables therapeutic efficacy
Effective therapy of polymyositis in mice via selective inhibition of the immunoproteasome
Effective therapy of polymyositis in mice via selective inhibition of the immunoproteasome
Co-inhibition of immunoproteasome subunits LMP2 and LMP7 is required to block autoimmunity
Immunoproteasome inhibition reduces the T helper 2 response in mouse models of allergic airway inflammation
Immunoproteasome Inhibition Reduces the T Helper 2 Response in Mouse Models of Allergic Airway Inflammation
Immunoproteasome inhibition attenuates experimental psoriasis
Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation
No prolongation of skin allograft survival by immunoproteasome inhibition in mice
The role of immunoproteasome subunit LMP7 in modulating T-helper cell differentiation and progression of autoimmune diseases
Recent insights how combined inhibition of immuno/proteasome subunits enables therapeutic efficacy
Effective therapy of polymyositis in mice via selective inhibition of the immunoproteasome
Effective therapy of polymyositis in mice via selective inhibition of the immunoproteasome
Co-inhibition of immunoproteasome subunits LMP2 and LMP7 is required to block autoimmunity
Immunoproteasome inhibition reduces the T helper 2 response in mouse models of allergic airway inflammation
Immunoproteasome Inhibition Reduces the T Helper 2 Response in Mouse Models of Allergic Airway Inflammation
Immunoproteasome inhibition attenuates experimental psoriasis
Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation
No prolongation of skin allograft survival by immunoproteasome inhibition in mice
The role of immunoproteasome subunit LMP7 in modulating T-helper cell differentiation and progression of autoimmune diseases
Recent insights how combined inhibition of immuno/proteasome subunits enables therapeutic efficacy
Effective therapy of polymyositis in mice via selective inhibition of the immunoproteasome
Effective therapy of polymyositis in mice via selective inhibition of the immunoproteasome